Boryung reports slow sales and profit down in 2005.

Published: 2006-02-03 06:57:00

Updated: 2006-02-03 06:57:00

Boryung pharmaceutical company announced the 2005 financial reports at 167,979 million won of sales, 5.9% down from the previous year, 6,839 million won of operating incomes and 5,938 million won of ordinary incomes, which was 55.2% and 52.7% down from the previous year, and 3,019 million won of ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK